Key Highlights
- Greenspace Health secures Series B growth equity investment from ABS Capital Partners.
- The funding will fuel innovation and expansion in Measurement-Based Care (MBC) technology.
- Over 5 million assessments completed, supporting 500+ MBC implementations across healthcare providers.
- Greenspace’s platform improves clinical outcomes, provider efficiency, and patient engagement.
- Cal Wheaton, Partner at ABS Capital, joins Greenspace’s Board of Directors.
Source: Business Wire
Notable Quotes
- “Measurement-Based Care is no longer optional—it is essential to ensure individuals have access to care that leads to meaningful improvement. With ABS Capital’s investment, we are advancing the next generation of MBC technology to support providers in delivering the highest standard of care.” — Jeremy Weisz, CEO & Co-Founder at Greenspace Health
- “The need for real-time data and insights has never been greater. Greenspace is uniquely positioned to transform care delivery, improve clinical outcomes, and enable value-based models. We’re excited to support their continued growth and impact.” — Cal Wheaton, Partner at ABS Capital
- “The behavioral health industry has historically lacked the data needed for continuous innovation. As value-based care becomes a standard, Measurement-Based Care is the foundation for improving quality, demonstrating impact, and accessing new care models.” — Simon Weisz, President & Co-Founder at Greenspace Health
Why This Matters
The behavioral healthcare industry is undergoing a significant shift towards value-based care, with data-driven insights and measurement playing a crucial role. Greenspace Health’s Series B investment from ABS Capital underscores the growing importance of Measurement-Based Care (MBC) in enhancing clinical decision-making, patient engagement, and treatment outcomes. By equipping providers with real-time, evidence-based tools, Greenspace is helping transform behavioral healthcare into a more effective, accountable, and person-centered system.
